Form D · Biotechnology
65Bio Inc.
Wellesley, MA · CIK 0001821284
Offering snapshot reported Aug 17, 2020 · SEC filing
- Reported sold
- $1.78M Offering amount: $4M
- Investors reported
- 6 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jul 16, 2020 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 17, 2020 | Initial | $1,776,000 | No comparison | 6 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-373353
Source: Form D, filed Aug 17, 2020. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Joseph Baron | Director |
| Daniel Gressel | Director |
| Jonathan Reis | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
65 William Street Suite 200
Wellesley, MA, 02481
Wellesley, MA, 02481